MétaCan
Menu
Back to cohort
Record W4407799935 · doi:10.1097/qai.0000000000003646

Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C

2025· article· en· W4407799935 on OpenAlexafffund
Jim Young, Shouao Wang, Rachel Sacks‐Davis, Ashleigh C. Stewart, Daniela K van Santen, Marc van der Valk, Joseph Doyle, Gail Matthews, Juan Berenguer, Linda Wittkop, Karine Lacombe, Andri Rauch, Mark Stoové, Margaret Hellard, Marina B. Klein

Bibliographic record

VenueJAIDS Journal of Acquired Immune Deficiency Syndromes · 2025
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsInstitute of Infection and ImmunityHIV Legal NetworkMcGill UniversityMcGill University Health Centre
FundersNational Health and Medical Research CouncilMedical Research CouncilNational Science FoundationCanadian Institutes of Health ResearchInstituto de Salud Carlos IIIViiV HealthcareSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAustralian GovernmentGilead SciencesMinisterie van Volksgezondheid, Welzijn en SportBristol-Myers SquibbAstraZenecaMinisterio de Ciencia e InnovaciónBurnet Institute
KeywordsMedicineTransient elastographyCirrhosisFibrosisHepatitis CInternal medicineRegressionChronic hepatitisRegression analysisLiver diseaseLiver fibrosisHepatitis C virusHepatic fibrosisGastroenterologyStatisticsImmunologyVirusMathematics

Abstract

fetched live from OpenAlex

BACKGROUND: Successful treatment of hepatitis C virus (HCV) can lead to liver fibrosis regression. It is not known who will experience fibrosis regression or how quickly it will occur. METHODS: We modeled transient elastography (TE) measurements from 1470 HIV-HCV coinfected participants followed in cohorts contributing data to InCHEHC, an international collaboration. Participants were eligible if they had at least 1 TE measurement in the year before starting a successful direct-acting antiviral treatment for HCV. This measurement was used to classify participants into 1 of 3 fibrosis subgroups. We analyzed measurement sequences in each subgroup using a covariate-adjusted generalized additive mixed model, with an adaptive spline representing changes in the mean measurement before, during, and after treatment. RESULTS: Each fibrosis subgroup had a distinctly different response. Most participants with cirrhosis (F4, TE ≥14.6 KPa) before HCV treatment did not show meaningful fibrosis regression-approximately 70% were predicted to remain >12 KPa 3 years after treatment ended. Participants with significant fibrosis (F2-F3, TE ≥7.2 and <14.6 KPa) showed appreciable regression in the first 2 years after treatment, falling on average to levels <7.2 KPa. Those without fibrosis before treatment (F0-F1) did not progress. CONCLUSIONS: Most coinfected people with cirrhosis before HCV cure will remain cirrhotic. For those with significant fibrosis, regression can be expected within 2 years to levels not normally associated with an increased risk of end-stage liver disease. A TE measurement 2 years after cure should give a reliable estimate of residual fibrosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.263
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAIDS Journal of Acquired Immune Deficiency SyndromesSame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207